Parenchymal, but not leukocyte, TNF receptor 2 mediates T cell-dependent hepatitis in mice

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 2129-2137

  Schümann, Jens ^a,c   Mühlen, Katrin ^a   Kiemer, Alexandra K ^b   Vollmar, Angelika M ^b   Tiegs, Gisa ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PSEUDOMONAS EXOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HEPATITIS; KUPFFER CELL; LEUKOCYTE; LEUKOCYTE ACTIVATION; LIVER INJURY; LIVER PARENCHYMA; MALE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0037442019     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.2129     Document Type: Article

References (50)

1. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666.
2. Kimura, K., T. Taguchi, I. Urushizaki, R. Ohno, O. Abe, H. Furue, T. Hattori, H. Ichihashi, K. Inoguchi, and H. Majima. 1987. Phase I study of recombinant human tumor necrosis factor. Cancer Chemother. Pharmacol. 20:223.
3. Tiegs, G., M. Wolter, and A. Wendel. 1989. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 38:627.
4. Schümann, J., and G. Tiegs. 1999. Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. Toxicology 138:103.
5. Schümann, J., S. Angermüller, R. Bang, M. Lohoff, and G. Tiegs. 1998. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J. Immunol. 161:5745.
6. Schümann, J., D. Wolf, A. Pahl, K. Brune, T. Papadopoulos, N. van Rooijen, and G. Tiegs. 2000. Importance of Kupffer cells for T cell-dependent liver injury in mice. Am. J. Pathol. 157:1671.
7. Faggioni, R., J. Jones-Carson, D. A. Reed, C. A. Dinarello, K. R. Feingold, C. Grunfeld, and G. Fantuzzi. 2000. Leptin (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor α and IL-18. Proc. Natl. Acad. Sci. USA 97:2367.
8. Grell, M., H. Wajant, G. Zimmermann, and P. Scheurich. 1998. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. USA 95:570.
9. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
10. Küsters, S., G. Tiegs, L. Alexopoulou, M. Pasparakis, E. Douni, G. Künstle, H. Bluethmann, A. Wendel. K. Pfizenmaier, G. Kollias, and M. Grell. 1997. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27:2870.
11. Wolf. D., R. Hallmann, G. Sass, M. Sixt, S. Küsters, B. Fregien, C. Trautwein, and G. Tiegs. 2001. TNF-α-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis. J. Immunol. 166:1300.
12. Schümann, J., H. Bluethmann, and G. Tiegs. 2000. Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1-and TNFR2-dependent liver toxicity in mice. Immunol. Lett. 74:165.
13. Hayder, H., R. V. Blanden, H. Körner, D. S. Riminton, J. D. Sedgwick, and A. Müllbacher. 1999. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin. J. Immunol. 163: 1516.
14. Leist, M., F. Gantner, S. Jilg, and A. Wendel. 1995. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154:1307.
15. Baud, V., and M. Karin. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11:372.
16. Douni, E., and G. Kollias. 1998. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNF-R. J. Exp. Med. 188:1343.
17. Heller, R. A., K. Song, N. Fan, and D. J. Chang. 1992. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47.
18. Bigda, J., I. Beletsky, C. Brakebusch, Y. Varfolomeev, H. Engelmann, J. Bigda, H. Holtmann, and D. Wallach. 1994. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180:445.
19. Weiss, T., M. Grell, K. Siemienski, F. Mühlenbeck, H. Dürkop, K. Pfizenmaier, P. Scheurich, and H. Wajant. 1998. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J. Immunol. 161:3136.
20. Grell, M., G. Zimmermann, E. Gottfried, C.-M. Chen, U. Grünwald, D. C. S. Huang, Y.-H. W. Lee, H. Dürkop, H. Engelmann, P. Scheurich, et al. 1999. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18:3034.
21. Duckett, C. S., and C. B. Thompson. 1997. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11:2810.
22. Chan, F. K.-M., and M. J. Lenardo. 2000. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur. J. Immunol. 30:652.
23. Volpes, R., J. J. van den Oord, R. de Vos, and V. J. Desmet. 1992. Hepatic expression of type A and type B receptors for tumor necrosis factor. J. Hepatol. 14:361.
24. Marinos, G., N. V. Naoumov, S. Rossol, F. Torre, P. Y. N. Wong, H. Gallati, B. Protmann, and R. Williams. 1995. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology 108:1453.
25. Spengler, U., R. Zachoval, H. Gallati, M.-C. Jung, R. Hoffmann, G. Riethmüller, and G. Pape. 1996. Serum levels and in situ expression of TNF-α and TNF-α binding proteins in inflammatory liver diseases. Cytokine 8:864.
26. Kallinowski, B., K. Haseroth, G. Marinos, C. Hanck, W. Stremmel, L. Theilmann, M. V. Singer, and S. Rossol. 1998. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin. Exp. Immunol. 111:269.
27. Streetz, K., L. Leifeld, D. Grundmann, J. Ramakers, K. Eckert, U. Spengler, D. Brenner, M. Manns, and C. Trautwein. 2000. Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119:446.
28. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
29. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. F. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour necrosis factor but normal T-cell development in TNF receptor 2-deficient mice. Nature 372:560.
30. Van Rooijen, N., J. Bakker, and A. Sanders. 1997. Transient suppression of macrophage functions by liposome-encapsulated drugs. Trends Biotechnol. 15: 178.
31. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174:83.
32. -/- mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 7:419.
33. Bergmeyer, H. U. 1984. Methods in Enzymatic Analysis, 3rd Ed. Verlag Chemie, Weinheim.
34. Fehninger, T. A., M. H. Shah, M. J. Turner, J. B. Van Deusen, S. P. Whitman, M. A. Cooper, K. Suzuki, M. Wechser, F. Goodsaid, and M. A. Caligiuri. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162:4511.
35. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts." prepared from a small number of cells. Nucleic Acids Res. 17:6419.
36. Wolf, D., J. Schümann, K. Koerber, A. K. Kiemer, A. M. Vollmar, G. Sass, T. Papadopoulos, R. Bang, S. D. Klein, B. Brüne, and G. Tiegs. 2001. Low-molecular-weight hyaluronic acid induces nuclear factor-κB-dependent resistance against tumor necrosis factor α-mediated liver injury in mice. Hepatology 34:535.
37. Liu, Z.-X., S. Govindarajan, S. Okamoto, and G. Dennert. 2000. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J. Immunol. 164:6480.
38. Seglen, P. O. 1991. Preparation of rat liver cells: enzymatic requirements for tissue dispersion. Exp. Cell Res. 2:391.
39. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153:1778.
40. Ando, K., T. Moriyama, L. G. Guidotti, S. Wirth, R. D. Schreiber, H. J. Schlicht, S. Huang, and F. V. Chisari. 1993. Mechanisms of class I restricted immunopathology: a transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1541.
41. Kennedy, D. W., and J. L. Abkowitz. 1997. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90:986.
42. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323.
43. Mohler, K. M., D. S. Torrance, C. A. R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M. B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548.
44. Bemelmans, M. H. A., D. J. Gouma, and W. A. Buurman. 1993. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J. Immunol. 150:2007.
45. Jaeschke, H., A. Farhood, and C. E. Smith. 1991. Neutrophil- induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am. J. Physiol. 261:G1051.
46. Jaeschke, H., A. Farhood, and C. W. Smith. 1990. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 4:3355.
47. Koerber, K., G. Sass, A. K. Kiemer, A. M. Vollmar, and G. Tiegs. 2002. In vivo regulation of inducible NO-synthase in immune mediated liver injury in mice. Hepatology 36:1061.
48. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.
49. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
50. Willuweit, A., G. Sass, A. Schöneberg, U. Eisel. G. Tiegs, and M. Clauss. 2001. Chronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells. J. Immunol. 167:3944.